Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study. [electronic resource]
Producer: 20160614Description: 231-7 p. digitalISSN:- 1535-5667
- 3-Iodobenzylguanidine -- adverse effects
- Adolescent
- Adrenal Gland Neoplasms -- radiotherapy
- Adult
- Arsenic Trioxide
- Arsenicals -- adverse effects
- Brain Neoplasms -- radiotherapy
- Child
- Child, Preschool
- Drug Resistance, Neoplasm
- Female
- Humans
- Male
- Neuroblastoma -- radiotherapy
- Oxides -- adverse effects
- Paraganglioma -- radiotherapy
- Pheochromocytoma -- radiotherapy
- Radiation-Sensitizing Agents -- adverse effects
- Radiopharmaceuticals -- adverse effects
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.